Secreted ovarian stromal substance inhibits ovarian epithelial cell proliferation

Gynecologic Oncology

Volumn 59, Issue 1, 1995, Pages 67-74

  Karlan, Beth Y ^a   Baldwin, Rae Lynn ^a   Cirisano, Frank D ^a   Mamula, Paul W ^a   Jones, Jolynda ^b   Lagasse, Leo D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; STROMA CELL;

BIOLOGICAL FACTORS; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMAN; MOLECULAR WEIGHT; OVARIAN NEOPLASMS; OVARY; STROMAL CELLS; SUPPORT, NON-U.S. GOV'T;

EID: 0028881241     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1006/gyno.1995.1269     Document Type: Article

References (34)

1. Boring, C. C., Squires, T. S., Tong, T, and Montgomery, S. Cancer Statistics 1994, CA-Cancer J. Clin. 44, 7-26 (1994).
2. Donjacour, A. A., and Cunha, G. R., Stromal regulation of epithelial function, in Regulatory mechanisms in breast cancer (M. Lippman and R. Dickson, Eds.), Kluwer Academic, Boston, pp. 335-364 (1992).
3. Lin, C. Q., and Bissell, M. J., Multi-faceted regulation of cell differentiation by extracellular matrix, FASEB J. 7, 737-743 (1993).
4. Sakakura, T., Sakagami, Y., and Nishizuka, Y. Acceleration of mammary cancer development by grafting of fetal mammary mesenchymes in C3H mice, Gann 70, 459-466 (1979).
5. Hayaski, N., and Cunha, G. R., Mesenchyme-induced changes in the neoplastic characteristics of the dunning prostatic adenocarcinoma, Cancer Res. 51, 4924-4930 (1991).
6. Krasnow, J. Advances in understanding ovarian physiology: Regulation of steroidogenic enzymes in ovarian follicular differentatiation, Semin. Reprod. Endocrin. 9, 283-302 (1991).
7. Magoffin, D. A., Regulation of differentiated functions in ovarian theca cells, Semin. Reprod. Endocrinol. 9, 321-331 (1991).
8. Nicosia, S. V., Saunders, B. O., Acevedo-Duncan, M. E., Setrakin, S., and Degregorio, R. Biopathology of ovarian mesothelium, in Ultrastructure of the ovary (G. Familiari, S. Makabe, and P. M. Motta, Eds.), Kluwer Academic, Dordrecht/Norwell, MA, pp. 287-310 (1991).
9. Blaustein, A., and Hyun, L. Surface cells of the ovary and pelvic peritoneum: A histochemical and ultrastructure comparison, Gynecol. Oncol. 8, 34-43 (1979).
10. Fromm, G. L., Gershenson, D. M., and Silva, E. G., Papillary serous carcinoma of the peritoneum, Obstei. Gynecol. 75, 89-95 (1990).
11. Resta, L., Russo, S., Colucci, G. A., and Prat, J. Morphologic precursors of ovarian epithelial tumors, Obstet. Gynecol. 82, 181-186 (1993).
12. Godwin, A. K., Testa, J. R., and Hamilton, T. C., The biology of ovarian cancer development, Cancer 71, 530-536 (1993).
13. Whittemore, A. S., Harris, R., Itnyre, J., and The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies, Am. J. Epidemiol 136, 1184-1203 (1992).
14. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., and Self, S.G. Ovarian tumors in a cohort of infertile women, N. Engl. J. Med. 331, 771-776 (1994).
15. Karlan, B. Y., Jones, J., Greenwald, M., and Lagasse, L. Steroid hormone effects on the proliferation of human ovarian surface epithelia in vitro, Am. J. Obstet. Gynecol. 173, 97-104 (1995).
16. Karlan, B. Y., Jones, J., Slamon, D. J., and Lagasse, L. D., Gluccocorticoids stablize HER-2/Wu messenger RNA in human epithelial ovarian carcinoma cells, Gynecol. Oncol. 53, 70-77 (1994)
17. Jones, J., Lagasse, L. D., and Karlan, B. Y., Steroid hormone regulation of HER-2Ineu mRNA expression in four human ovarian carcinoma cell lines, Gynecol. Oncol. 55, 421-426 (1994).
18. Kruk, P. A., Maines-Bandiera, S. L., and Auersperg, H. A simplified method to culture human ovarian surface epithelium, Lab. Invest. 63, 132-136 (1990).
19. Auersperg, N., Siemens, C. H., and Myrdal, S. E., Human ovarian surface epithelium in primary culture, In Vitro 20, 743-755 (1984).
20. Bligh, E. G., and Dyer, W. J., A rapid method of total lipid extractment and purification, Can. J. Biochem. Physiol. 37(8), 911-917 (1959).
21. Moll, R., Levy, R., Czemobilsky, B., Hohlweg-Majert, P., Dallenbach-Heuweg, G, and Franke, W. W., Cytokeratins of normal epithelial and some neoplasms of the female genital tract, Lab. Invest. 49, 599-610 (1983).
22. Miettinen, M., Lehto, V.-P., and Virtanen, I. Expression of intermediate filaments in normal ovaries and ovarian epithelial sex cord-stromal, and germinal tumors, Int. J. Gynecol. Pathol. 2, 64-71 (1983).
23. Van der Hooff, A. Connective tissue as an active participant in the process of malignant growth, AntiCancer Res. 6, 775-780 (1986).
24. DeCosse, J. J., Gossens, C. L., Kuzma, J. F., and Unsworth, B. R., Embryonic inductive tissues that cause histological differentiation of murine mammary carcinoma in vitro, J. Natl. Cancer Inst. 54, 913-921 (1975).
25. Fukamachi, H., Mizuno, T, and Kim, Y. S., Morphogenesis of human colon cancer cells with fetal rat mesenchymes in organ culture, Experientia 42, 312-315 (1986).
26. Speroff, L., Glass, R. H., and Kase, H. G., Regulation of the menstrual cycle, in Clinical gynecologic endocrinology and infertility (L. Speroff, R. H., Glass, and N. G. Kase, Eds.), Williams & Wilkins, Baltimore, 4th ed., pp. 91-119 (1989).
27. Miller, D. S., Teng, N. N. H, and Ballon, S. C., Epithelial ovarian carcinoma in patients with intersex disorders: The role of pituitary gonadotropins in ovarian tumorigenesis, Gynecol. Oncol. 24, 299-308 (1986).
28. Karlan, B. Y., Raffel, L., Sarti, D. A., Rotter, J. I., Platt, L. D., Walla, C. A., Crevenkovic, G., Chen, D., Smrt, C., Garber, C., CAne, P., and Lopez, E. A multidisciplinary approach to the early detection of ovarian carcinoma: Rationale, protocol design, and early results, Am. J. Obstet. Gynecol. 9, 494-501 (1993).
29. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K, Tavtigian, S., Liu, Q., Cochran, C., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science 266, 66-71 (1994).
30. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., et al. BRCA1 mutations in primary breast and ovarian carcinomas, Science 266, 120-122 (1994).
31. Petraglia, F., MiMeo, G., Storchi, R., Segre, A., Facchinetti, F., Szalay, S., Volpe, A., and Genazzani, A. R., Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: Changes during the menstrual cycle, Am. J. Obstet. Gynecol. 157, 142-146 (1987)
32. Kasson, B. G., Adashi, E. Y., and Hsueh, A. J., W. Arginine vasopressin the testis: an intragonadal peptide control system, Endocrinol. Rev. 7, 156-168 (1986).
33. Pence, J. C., and Shorter, N. Autoregulation of neuroblastoma growth by vasoactive intestinal peptide, J. Ped. Surg. 27, 935-944 (1992).
34. Moody, T., Zia, T., Draoui, M., Brenneman, D. E., et al. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth, Proc. Natl. Acad. Sci. 90, 4345-4349 (1993).